Keurig Dr Pepper Inc. (NASDAQ:KDP) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP) have been given an average rating of “Moderate Buy” by the seventeen ratings firms that are presently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $39.33.

Several analysts have issued reports on the stock. Morgan Stanley raised shares of Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 25th. HSBC raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and upped their target price for the company from $36.00 to $42.00 in a report on Friday, April 25th. Royal Bank of Canada reiterated an “outperform” rating and set a $42.00 price target on shares of Keurig Dr Pepper in a report on Tuesday, April 22nd. Finally, UBS Group upped their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, April 17th.

Keurig Dr Pepper Stock Performance

KDP opened at $33.83 on Thursday. The business’s 50-day simple moving average is $34.24 and its 200 day simple moving average is $33.02. Keurig Dr Pepper has a 52-week low of $30.12 and a 52-week high of $38.28. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53. The firm has a market capitalization of $45.95 billion, a PE ratio of 20.50, a PEG ratio of 2.42 and a beta of 0.52.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion for the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business’s quarterly revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.38 EPS. As a group, sell-side analysts expect that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Insider Buying and Selling at Keurig Dr Pepper

In other news, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction on Thursday, April 17th. The stock was sold at an average price of $35.59, for a total value of $427,080.00. Following the transaction, the insider now owns 154,511 shares in the company, valued at approximately $5,499,046.49. This trade represents a 7.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the business’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $32.65, for a total value of $2,740,967,500.00. Following the transaction, the insider now directly owns 134,113,479 shares of the company’s stock, valued at $4,378,805,089.35. This trade represents a 38.50% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 84,863,850 shares of company stock valued at $2,772,203,450 in the last ninety days. 0.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in Keurig Dr Pepper by 21.3% in the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company’s stock valued at $4,962,338,000 after buying an additional 25,425,644 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Keurig Dr Pepper by 108.1% during the 1st quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company’s stock valued at $1,330,565,000 after acquiring an additional 20,196,835 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Keurig Dr Pepper by 36.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock valued at $1,755,564,000 after acquiring an additional 14,473,054 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its position in Keurig Dr Pepper by 65.0% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company’s stock worth $681,579,000 after acquiring an additional 8,363,192 shares during the last quarter. Finally, Norges Bank acquired a new position in Keurig Dr Pepper in the 4th quarter worth about $197,819,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.